Conference-Service.com stellt der Öffentlichkeit ein Kalendarium wichtiger Konferenzen, Symposien und sonstiger Tagungen im wissenschaftlich-technischen Bereich zur Verfügung. Obwohl das Verzeichnis mit großer Sorgfalt zusammengestellt und ständig aktualisiert wird, weisen wir auf die Möglichkeit von Fehlern ausdrücklich hin. Bitte vergewissern Sie sich immer beim Veranstalter, bevor Sie über die Teilnahme oder Nichtteilnahme an einer Konferenz entscheiden.
Organisatoren können kostenlos ihre Konferenzankündigungen veröffentlichen.
The main aims of this meeting are:
a) To establish and develop the field of cardio-oncology in Israel.
b) To bring together cardiologists, oncologists, hemato-oncologists and general practitioners from Israel and worldwide.
c) To bring together national and international medical and para-medical disciplines involved, including the fields of imaging, biomarkers and others.
d) To give stage for basic scientists and pharma companies involved in the development of novel antineoplastic treatments with potential for off-target cardiovascular effects.
e) To contribute to the development of international recommendations and guidelines in the field.
Don't miss the opportunity to join peers and key opinion leaders in Tel Aviv, Israel, 15-16 June, 2017. Get a head start, visit IMCO 2017 website.
The second day will be dedicated to hands on, 6 stations will be available for ERCP, EUS-FNA, T.EUS, GI bleeding management, EMR &ESD. This second day should be interactive between the participants and the experts, 4 workshops will be organized and also 3 sessions of oral communications in which participants will debate with the experts. Abstracts presented during EUS-ENDO will be published in Endoscopic Ultrasound review.
An outstanding faculty of speakers from the United States and Europe has committed in this meeting.
The conference agenda will focus on new translational advances in the treatment of cancer as well as provide updates of conventional therapies for a number of the most common tumor types. The meeting objectives are designed to introduce the audience to the latest information on targeted therapies, immunotherapies and emerging treatments in early development.
Leading international and national scientists and physicians will address recent advances in breast cancer research, personalized therapy, and the latest clinical data impacting the treatment of breast cancer. Cutting-edge lectures, panel discussions, and interactive question-and-answer sessions will provide a unique opportunity for participants to engage with pioneers as they share their perspectives and personal experiences on the challenges and ongoing controversies in breast cancer.T
European Cancer Genomics research is particularly strong in the Heidelberg area, with three International Cancer Genome Consortium (www.icgc.org) projects being currently pursued with significant participation from Heidelberg institutions, including EMBL. As in our 2015 meeting, a large number of renowned speakers will be invited, with a strong representation of overseas speakers. The atmosphere at the conference will make this an exceptional event with cutting edge science, extensive scientific discussions and ample possibilities for meetings between and after sessions to facilitate in-depth discussions and new collaborations.
Stand vom 24. April 2017